Correlation Between Erasca and IO Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Erasca and IO Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and IO Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and IO Biotech, you can compare the effects of market volatilities on Erasca and IO Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of IO Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and IO Biotech.

Diversification Opportunities for Erasca and IO Biotech

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Erasca and IOBT is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and IO Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IO Biotech and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with IO Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IO Biotech has no effect on the direction of Erasca i.e., Erasca and IO Biotech go up and down completely randomly.

Pair Corralation between Erasca and IO Biotech

Given the investment horizon of 90 days Erasca Inc is expected to generate 0.78 times more return on investment than IO Biotech. However, Erasca Inc is 1.28 times less risky than IO Biotech. It trades about 0.0 of its potential returns per unit of risk. IO Biotech is currently generating about -0.01 per unit of risk. If you would invest  493.00  in Erasca Inc on September 3, 2024 and sell it today you would lose (207.00) from holding Erasca Inc or give up 41.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Erasca Inc  vs.  IO Biotech

 Performance 
       Timeline  
Erasca Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Erasca unveiled solid returns over the last few months and may actually be approaching a breakup point.
IO Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in IO Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, IO Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Erasca and IO Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Erasca and IO Biotech

The main advantage of trading using opposite Erasca and IO Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, IO Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IO Biotech will offset losses from the drop in IO Biotech's long position.
The idea behind Erasca Inc and IO Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals